baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Call 128 6MK 20.06.../ DE000ME2EZD8 /

2024-07-26 6:06:47 PM	Chg.-0.10	Bid10:00:33 PM	Ask10:00:33 PM	Underlying	Strike price	Expiration date	Option type
1.03EUR	-8.85%	- Bid Size: -	- Ask Size: -	MERCK CO. D...	128.00 -	2025-06-20	Call

GlobeNewswire 06-27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product

GlobeNewswire 06-25 Qure.ai announces strategic investment by Merck Global Health Innovation Fund to boost innovation of...

GlobeNewswire 06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...

GlobeNewswire 06-06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...

GlobeNewswire 06-05 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors

GlobeNewswire 06-03 Biolojic Design Enters into a Multi-Target Drug Discovery Collaboration with Merck KGaA, Darmstadt, ...

TeleTrader 05-29 Merck to buy biotech firm EyeBio for up to $3B

GlobeNewswire 05-29 Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...

GlobeNewswire 05-29 Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study

GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-06 IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...

GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 02-02 Merck Group to expand investment in South Korea

TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B

TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 2023-12-19 Unnatural Products, Inc. Announces $32 Million in Series A Funding Led by Merck Global Health Innova...

GlobeNewswire 2023-12-14 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

GlobeNewswire 2023-12-12 C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degr...

GlobeNewswire 2023-12-05 HiberCell, Inc. Announces Clinical Collaboration with Merck to Evaluate HC-7366, an Activator of ISR...

Morgan Stanley Call 128 6MK 20.06.../ DE000ME2EZD8 /

If you wish to receive reply to your feedback, please provide your email address.